Zentek Ltd. (TSXV: ZEN)

Market Cap	129.04M
Revenue (ttm)	39.36K
Net Income (ttm)	-10.74M
Shares Out	104.06M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,677
Open	1.230
Previous Close	1.260
Day's Range	1.200 - 1.300
52-Week Range	0.750 - 2.120
Beta	0.78
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 13, 2025

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in No...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2008
• Employees: 24
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: ZEN

Financial Performance

In 2023, Zentek's revenue was 29,816, a decrease of -59.07% compared to the previous year's 72,855. Losses were -11.70 million, -18.80% less than in 2022.